Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials (Q32034037)
scientific article
Language:
(P31) (Q13442814)
(Q815382)
(P304) 343-353
(P407) (Q1860)
(P433) 2
(P478) 19
(P577) Monday, January 1, 2001
(P921) (Q815382)
(Q412178)
(Q128581)
(P1433) (Q400292)
(P1476) "Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials" (language: en)
(P2093) J G Klijn
R W Blamey
F Boccardo
T Tominaga
L Duchateau
R Sylvester
Combined Hormone Agents Trialists' Group and the European Organization for Research and Treatment of Cancer
other details
description scientific article

External Links